Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
31
NCT03481803
A Phase IIa Study With Escalating Dose of MS1819-SD
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 27, 2017
Completion: Jun 29, 2018
NCT04302662
Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs
Start: Jun 27, 2019
Completion: Jun 3, 2021